Citigroup’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$268K Sell
18,610
-16,656
-47% -$240K ﹤0.01% 3216
2025
Q1
$243K Sell
35,266
-4,695
-12% -$32.4K ﹤0.01% 3325
2024
Q4
$212K Buy
39,961
+4,636
+13% +$24.6K ﹤0.01% 3550
2024
Q3
$129K Buy
35,325
+24,673
+232% +$90.1K ﹤0.01% 3867
2024
Q2
$29.1K Sell
10,652
-52,217
-83% -$143K ﹤0.01% 4144
2024
Q1
$219K Buy
+62,869
New +$219K ﹤0.01% 3246
2022
Q4
Sell
-1
Closed 5080
2022
Q3
$0 Sell
1
-906
-100% ﹤0.01% 5487
2022
Q2
$2K Sell
907
-3,009
-77% -$6.64K ﹤0.01% 5130
2022
Q1
$10K Sell
3,916
-8,021
-67% -$20.5K ﹤0.01% 4769
2021
Q4
$45K Buy
11,937
+6,598
+124% +$24.9K ﹤0.01% 4358
2021
Q3
$33K Buy
5,339
+2,139
+67% +$13.2K ﹤0.01% 4237
2021
Q2
$31K Buy
3,200
+471
+17% +$4.56K ﹤0.01% 4395
2021
Q1
$25K Sell
2,729
-5,157
-65% -$47.2K ﹤0.01% 4457
2020
Q4
$38K Buy
7,886
+5,928
+303% +$28.6K ﹤0.01% 4263
2020
Q3
$8K Sell
1,958
-3,555
-64% -$14.5K ﹤0.01% 4456
2020
Q2
$25K Sell
5,513
-6,499
-54% -$29.5K ﹤0.01% 4116
2020
Q1
$39K Buy
12,012
+3,789
+46% +$12.3K ﹤0.01% 3977
2019
Q4
$35K Buy
8,223
+2,892
+54% +$12.3K ﹤0.01% 4212
2019
Q3
$21K Sell
5,331
-5,380
-50% -$21.2K ﹤0.01% 4262
2019
Q2
$50K Buy
10,711
+277
+3% +$1.29K ﹤0.01% 4099
2019
Q1
$43K Buy
10,434
+336
+3% +$1.39K ﹤0.01% 4119
2018
Q4
$35K Sell
10,098
-467
-4% -$1.62K ﹤0.01% 4137
2018
Q3
$45K Buy
10,565
+5,037
+91% +$21.5K ﹤0.01% 4150
2018
Q2
$21K Buy
+5,528
New +$21K ﹤0.01% 4376
2017
Q3
Sell
-1
Closed 4891
2017
Q2
$0 Sell
1
-82
-99% ﹤0.01% 5003
2017
Q1
$0 Sell
83
-28,723
-100% ﹤0.01% 4934
2016
Q4
$95K Buy
28,806
+26,457
+1,126% +$87.3K ﹤0.01% 3928
2016
Q3
$7K Sell
2,349
-537
-19% -$1.6K ﹤0.01% 4566
2016
Q2
$12K Buy
+2,886
New +$12K ﹤0.01% 4439